Glucose Health, Inc. SEC filings GLUC

Glucose Health, Inc. has 140 filings in SEC EDGAR's recent list, going back to Dec 7, 2007. Its latest annual report, Form 10-K, was filed on Mar 29, 2017 for the period ended Dec 31, 2016. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2017, covering the quarter ended Sep 30, 2017. The most recent current report (Form 8-K) was filed on Apr 11, 2017 (auditor change). The company's fiscal year ends on December 31.

Glucose Health, Inc. SEC filings
Form Description Filed Period
D Filing Oct 19, 2026 —
D Filing Oct 7, 2026 —
D Filing Oct 6, 2026 —
D Filing Oct 6, 2026 —
D Filing Sep 10, 2026 —
D Filing Jul 7, 2026 —
D Filing Feb 4, 2026 —
D Filing Dec 5, 2025 —
D/A Filing Jan 19, 2024 —
D Filing Dec 7, 2023 —
RW Filing Jun 28, 2023 —
S-1/A Amended registration statement Jan 9, 2023 —
S-1/A Amended registration statement Sep 6, 2022 —
S-1/A Amended registration statement Aug 5, 2022 —
S-1 Registration statement Jun 1, 2022 —
D Filing Mar 9, 2021 —
D Filing Jun 19, 2020 —
D Filing May 12, 2020 —
D Filing May 3, 2019 —
15-12G Deregistration Apr 16, 2018 —
NT 10-K Filing Apr 2, 2018 Dec 31, 2017
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
10-Q Quarterly report Aug 21, 2017 Jun 30, 2017
NT 10-Q Filing Aug 14, 2017 Jun 30, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
8-K Current report
Auditor change
Apr 11, 2017 Apr 6, 2017
10-K Annual report Mar 29, 2017 Dec 31, 2016
10-Q Quarterly report Dec 21, 2016 Sep 30, 2016
NT 10-Q Filing Nov 14, 2016 Sep 30, 2016
10-Q Quarterly report Aug 22, 2016 Jun 30, 2016
NT 10-Q Filing Aug 15, 2016 Jun 30, 2016
10-Q Quarterly report May 23, 2016 Mar 31, 2016
NT 10-Q Filing May 16, 2016 Mar 31, 2016
10-K Annual report Apr 14, 2016 Dec 31, 2015
NT 10-K Filing Mar 30, 2016 Dec 31, 2015
8-K Current report
Other events
Mar 11, 2016 Jan 6, 2016
8-K Current report
Officer or director change
Feb 5, 2016 Feb 5, 2016
8-K Current report
Other events
Jan 27, 2016 Jan 27, 2016
10-Q Quarterly report Nov 23, 2015 Sep 30, 2015
NT 10-Q Filing Nov 16, 2015 Sep 30, 2015
10-Q Quarterly report Aug 18, 2015 Jun 30, 2015
NT 10-Q Filing Aug 14, 2015 Jun 30, 2015
8-K Current report
Auditor change
Aug 6, 2015 Jun 30, 2015
10-Q Quarterly report May 19, 2015 Mar 31, 2015
NT 10-Q Filing May 15, 2015 Mar 31, 2015
3 Initial insider ownership May 8, 2015 May 8, 2015
8-A12G Filing May 1, 2015 —
10-K Annual report Mar 30, 2015 Dec 31, 2014
8-K Current report
Officer or director change
Feb 12, 2015 Feb 10, 2015
8-K Current report
Other events
Dec 16, 2014 Dec 15, 2014
8-K Current report
Bylaw or fiscal year change
Nov 10, 2014 Nov 5, 2014
8-K/A Amended current report
Material agreement, Unregistered share sale, Change in control, Officer or director change
Oct 23, 2014 Oct 1, 2014
10-Q Quarterly report Oct 22, 2014 Sep 30, 2014
8-K Current report
Auditor change
Oct 7, 2014 Oct 3, 2014
8-K Current report
Material agreement, Officer or director change
Oct 2, 2014 Oct 1, 2014
10-Q Quarterly report Aug 12, 2014 Jun 30, 2014
8-K Current report
Officer or director change
Jul 25, 2014 Jul 22, 2014
10-Q Quarterly report Jul 16, 2014 Mar 31, 2014
UPLOAD Letter from the SEC Jul 1, 2014 —
10-K Annual report Jun 25, 2014 Dec 31, 2013
8-K Current report
Auditor change
May 5, 2014 Apr 30, 2014
10-K/A Amended annual report May 5, 2014 Dec 31, 2012
10-K/A Amended annual report Apr 24, 2014 Dec 31, 2012
8-K Current report
Officer or director change
Apr 23, 2014 Apr 21, 2014
8-K Current report
Material agreement, Agreement ended, Officer or director change, Bylaw or fiscal year change
Apr 15, 2014 Dec 19, 2013
NT 10-K Filing Mar 31, 2014 Dec 31, 2013
CORRESP Letter to the SEC Mar 19, 2014 —
UPLOAD Letter from the SEC Mar 6, 2014 —
CORRESP Letter to the SEC Feb 25, 2014 —
CORRESP Letter to the SEC Jan 28, 2014 —
UPLOAD Letter from the SEC Jan 14, 2014 —
CORRESP Letter to the SEC Jan 2, 2014 —
UPLOAD Letter from the SEC Dec 18, 2013 —
CORRESP Letter to the SEC Dec 4, 2013 —
UPLOAD Letter from the SEC Nov 20, 2013 —
10-Q Quarterly report Nov 14, 2013 Sep 30, 2013
8-K Current report
Material agreement
Aug 6, 2013 Aug 1, 2013
10-Q Quarterly report Aug 2, 2013 Jun 30, 2013
10-Q Quarterly report May 6, 2013 Mar 31, 2013
10-K Annual report Mar 22, 2013 Dec 31, 2012
S-8 Employee stock plan registration Mar 4, 2013 —
10-Q Quarterly report Nov 14, 2012 Sep 30, 2012
10-Q/A Amended quarterly report Sep 5, 2012 Jun 30, 2012
10-Q/A Amended quarterly report Aug 31, 2012 Jun 30, 2012
10-Q Quarterly report Aug 13, 2012 Jun 30, 2012
10-Q Quarterly report Jul 25, 2012 Mar 31, 2012
8-K Current report
Officer or director change
Jun 26, 2012 Jun 20, 2012
10-K Annual report May 31, 2012 Dec 31, 2011
NT 10-K Filing Mar 29, 2012 Dec 31, 2011
8-K Current report
Officer or director change
Feb 27, 2012 Feb 15, 2012
8-K Current report
Material agreement, Acquisition or sale of assets
Nov 22, 2011 Sep 26, 2011
10-Q Quarterly report Nov 21, 2011 Sep 30, 2011
8-K Current report
Officer or director change
Nov 16, 2011 Oct 10, 2011
NT 10-Q Filing Nov 14, 2011 Sep 30, 2011
UPLOAD Letter from the SEC Oct 27, 2011 —
10-K/A Amended annual report Sep 29, 2011 Jun 30, 2011
CORRESP Letter to the SEC Sep 28, 2011 —
10-Q/A Amended quarterly report Sep 28, 2011 Jun 30, 2011
UPLOAD Letter from the SEC Sep 20, 2011 —
10-Q Quarterly report Aug 22, 2011 Jun 30, 2011
NT 10-Q Filing Aug 12, 2011 Jun 30, 2011
10-Q Quarterly report May 23, 2011 Mar 31, 2011
10-Q Quarterly report May 23, 2011 Dec 31, 2010
NT 10-Q Filing May 16, 2011 Mar 31, 2011
10-K/A Amended annual report Apr 20, 2011 Dec 31, 2010
10-K Annual report Apr 14, 2011 Dec 31, 2010
NT 10-K Filing Mar 31, 2011 Dec 31, 2010
S-8 Employee stock plan registration Mar 29, 2011 —
10-Q Quarterly report Nov 22, 2010 Sep 30, 2010
NT 10-Q Bio-solutions form 12b25 093010 Nov 15, 2010 Sep 30, 2010
10-Q Quarterly report Aug 13, 2010 Jun 30, 2010
8-K Current report
Regulation FD disclosure, Other events
Jun 25, 2010 Jun 25, 2010
10-Q Quarterly report May 17, 2010 Mar 31, 2010
10-K Annual report Apr 15, 2010 Dec 31, 2009
NT 10-K Bio-solutions form 12b25 12/31/09 Mar 31, 2010 Dec 31, 2009
10-Q Quarterly report Nov 16, 2009 Sep 30, 2009
8-K Current report
Material agreement
Aug 18, 2009 Aug 17, 2009
10-Q Quarterly report Aug 14, 2009 Jun 30, 2009
10-Q Quarterly report May 14, 2009 Mar 31, 2009
424B3 Prospectus May 12, 2009 —
EFFECT Filing May 6, 2009 —
CORRESP Letter to the SEC May 4, 2009 —
UPLOAD Letter from the SEC Apr 24, 2009 —
CORRESP Letter to the SEC Apr 23, 2009 —
S-1/A Amended registration statement Apr 23, 2009 —
10-K/A Amended annual report Apr 23, 2009 Dec 31, 2008
S-1 Registration statement Mar 20, 2009 —
8-K Current report
Officer or director change
Mar 18, 2009 Mar 16, 2009
10-K Annual report Mar 16, 2009 Dec 31, 2008
8-K Current report
Unregistered share sale
Dec 23, 2008 Dec 18, 2008
10-Q Quarterly report Nov 14, 2008 Sep 30, 2008
8-K Current report
Material agreement, New debt
Sep 16, 2008 Sep 3, 2008
10-Q Quarterly report Aug 13, 2008 Jun 30, 2008
10-Q Quarterly report May 9, 2008 Mar 31, 2008
10KSB Bio-solutions form 10-ksb for the period december 31, 2007 Apr 10, 2008 Dec 31, 2007
NT 10-K Bio-solutions corp. form nt 10-k for the period 12/31/07 Apr 1, 2008 Dec 31, 2007
8-K Current report
Auditor change
Feb 1, 2008 Jan 29, 2008
424B3 Prospectus Dec 28, 2007 —
EFFECT Filing Dec 21, 2007 —
SB-2 Bio-solutions corp. form sb-2 Dec 7, 2007 —

Showing 140 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
GLUC (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bentonville, AR
SEC filer status
Smaller reporting company
SEC CIK
1420108
Former names
Bio-Solutions Corp. (until Dec 16, 2014)

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.